Correlation of Asp299Gly and Thr399Ile polymorphisms in toll‑like receptor 4 gene with digestive cancer risk: A meta-analysis

Zhao,Xinxin; Kang,Shan; Liu,Lingling; Zhang,Dongfeng

doi:10.3892/br.2012.32

Correlation of Asp299Gly and Thr399Ile polymorphisms in toll‑like receptor 4 gene with digestive cancer risk: A meta-analysis

Authors:
- Xinxin Zhao
- Shan Kang
- Lingling Liu
- Dongfeng Zhang
View Affiliations

Affiliations: Department of Public Health, Medical College of Qingdao University, Shandong 266021, P.R. China
Published online on: October 29, 2012 https://doi.org/10.3892/br.2012.32
Pages: 294-302

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this meta-analysis was to evaluate the correlation between the Asp299Gly and Thr399Ile polymorphisms in the toll‑like receptor 4 (TLR4) gene and the risk of digestive cancer. A comprehensive search in PubMed, Web of Science (ISI), the China National Knowledge Infrastructure (CNKI), the Database of Chinese Scientific and Technical Periodicals (VIP) and the China Biology Medical (CBM) literature databases, including all the studies until May 25 2012, was conducted in order to investigate the abovementioned correlation. Statistical analysis was performed using STATA version 10.1. A total of 12 case‑control studies were identified comprising 1,877 cancer patients and 3,181 controls for Asp299Gly polymorphism, and 8 case‑control studies with 1,062 cancer patients and 1,867 controls for Thr399Ile polymorphism. Following sensitivity analysis and excluding studies that deviated from the Hardy‑Weinberg equilibrium (HWE) in the controls, this meta‑analysis demonstrated a significant correlation between the G allele of the Asp299Gly polymorphism and increased risk of gastric cancer in dominant [fixed‑effect model (FEM): odds ratio (OR), 1.772; 95% confidence interval (CI), 1.340-2.343] and codominant (FEM: OR, 1.761, CI, 1.347-2.301) models. However, no significant correlation was detected for overall digestive and colorectal cancer. Furthermore, following the sensitivity analysis and exclusion of studies deviating from HWE in controls, no significant effect of the T allele of Thr399Ile polymorphism on overall digestive, gastric and colorectal cancer risk was demonstrated. This study suggests that the G allele of the TLR4 Asp299Gly polymorphism might be correlated with an increased risk of gastric cancer. However, this result needs to be further investigated by future studies.

View Figures

View References

1	Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin. 49:33–64. 1999. View Article : Google Scholar
2	Pharoah PD, Dunning AM, Ponder BA and Easton DF: Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer. 4:850–860. 2004. View Article : Google Scholar : PubMed/NCBI
3	Lin BK, Clyne M, Walsh M, et al: Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol. 164:1–4. 2006. View Article : Google Scholar : PubMed/NCBI
4	Le Marchand L: Genome-wide association studies and colorectal cancer. Surg Oncol Clin N Am. 18:663–668. 2009.PubMed/NCBI
5	Frank B, Hoffmeister M, Klopp N, Illig T, Chang-Claude J and Brenner H: Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk. Int J Cancer. 127:2822–2830. 2010. View Article : Google Scholar : PubMed/NCBI
6	Kutikhin AG: Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Human Immunol. 72:193–206. 2011. View Article : Google Scholar : PubMed/NCBI
7	El-Omar EM, Ng MT and Hold GL: Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene. 27:244–252. 2008. View Article : Google Scholar : PubMed/NCBI
8	Seya T, Shime H, Ebihara T, Oshiumi H and Matsumoto M: Pattern recognition receptors of innate immunity and their application to tumor immunotherapy. Cancer Sci. 101:313–320. 2010. View Article : Google Scholar : PubMed/NCBI
9	Türe-Ozdemir F, Gazouli M, Tzivras M, et al: Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res. 28:3697–3700. 2008.PubMed/NCBI
10	Santini D, Angeletti S, Ruzzo A, et al: Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol. 154:360–364. 2008. View Article : Google Scholar : PubMed/NCBI
11	Hellmig S, Fischbach W, Goebeler-Kolve M-E, Fölsch UR, Hampe J and Schreiber S: Association study of a functional toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma. 46:869–872. 2005. View Article : Google Scholar : PubMed/NCBI
12	Landi S, Gemignani F, Bottari F, et al: Polymorphisms within inflammatory genes and colorectal cancer. J Negat Results Biomed. 5:152006. View Article : Google Scholar : PubMed/NCBI
13	Boraska Jelavić T, Barisić M, Drmic Hofman I, et al: Microsatellite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer. Clin Genet. 70:156–160. 2006.PubMed/NCBI
14	Hold GL, Rabkin CS, Chow WH, et al: A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology. 132:905–912. 2007. View Article : Google Scholar : PubMed/NCBI
15	Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ and Perez-Perez GI: Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer. 7:702007. View Article : Google Scholar : PubMed/NCBI
16	Srivastava K, Srivastava A, Kumar A and Mittal B: Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver Int. 30:1067–1072. 2010. View Article : Google Scholar : PubMed/NCBI
17	Yang G, Qiu J, Wang X, Shen Z, Shao S and Li F: The single nucleotide polymorphisms of toll-like receptor 4 gene and colorectal cancer susceptibility. Chin J Gastrointest Surg. 14:814–815. 2011.
18	Davoodi H and Seow HF: Variant toll-like receptor 4 (Asp299Gly and Thr399Ile alleles) and toll-like receptor 2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy Asthma Immunol. 10:91–99. 2011.PubMed/NCBI
19	de Oliveira JG and Silva AE: Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population. World J Gastroenterol. 18:1235–1242. 2012.PubMed/NCBI
20	Agúndez JA, García-Martín E, Devesa MJ, et al: Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology. 82:35–40. 2012.PubMed/NCBI
21	Arbour NC, Lorenz E, Schutte BC, et al: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 25:187–191. 2000. View Article : Google Scholar : PubMed/NCBI
22	Norata GD, Garlaschelli K, Ongari M, et al: Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med. 258:21–27. 2005. View Article : Google Scholar : PubMed/NCBI
23	Brand S, Staudinger T, Schnitzler F, et al: The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn’s disease. Inflamm Bowel Dis. 11:645–652. 2005.PubMed/NCBI
24	Gazouli M, Mantzaris G, Kotsinas A, et al: Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol. 11:681–685. 2005. View Article : Google Scholar : PubMed/NCBI
25	Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
26	Khoury MJ, Little J, Gwinn M and Ioannidis JP: On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol. 36:439–445. 2007. View Article : Google Scholar : PubMed/NCBI
27	Ioannidis JP: Commentary: grading the credibility of molecular evidence for complex diseases. Int J Epidemiol. 35:572–578. 2006. View Article : Google Scholar : PubMed/NCBI
28	Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI
29	Houghton J and Wang TC: Helicobacter pylori and gastric cancer: a new paradigm for inflammation associated epithelial cancers. Gastroenterology. 128:1567–1578. 2005. View Article : Google Scholar
30	Peek RM and Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2:28–37. 2002. View Article : Google Scholar
31	Huang B, Zhao J, Li H, et al: Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65:5009–5014. 2005. View Article : Google Scholar : PubMed/NCBI
32	Huang B, Zhao J, Shen S, et al: Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res. 67:4346–4352. 2007. View Article : Google Scholar : PubMed/NCBI
33	Xiao H, Gulen MF, Qin J, et al: The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity. 26:461–475. 2007. View Article : Google Scholar : PubMed/NCBI
34	Fukata M, Chen A, Vamadevan AS, et al: Toll-like receptor-4 (TLR4) promotes the development of colitis-associated colorectal tumors. Gastroenterology. 133:1869–1881. 2007. View Article : Google Scholar : PubMed/NCBI
35	Fukata M and Abreu MT: Role of Toll-like receptors in gastrointestinal malignancies. Oncogene. 27:234–243. 2008. View Article : Google Scholar : PubMed/NCBI
36	Guo J, Loke J, Zheng F, et al: Functional linkage of cirrhosis-predictive single nucleotide polymorphism of toll-like receptor 4 to hepatic stellate cell responses. Hepatology. 49:960–968. 2009. View Article : Google Scholar : PubMed/NCBI
37	Guo J and Friedman SL: Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair. 3:212010. View Article : Google Scholar : PubMed/NCBI
38	Munafò MR and Flint J: Meta-analysis of genetic association studies. Trends Genet. 20:439–444. 2004.PubMed/NCBI
39	Ferwerda B, McCall MBB, Alonso S, et al: TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA. 104:16645–16650. 2007. View Article : Google Scholar : PubMed/NCBI